These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19122283)

  • 1. In vivo and in vitro antiviral activities of calycosin-7-O-beta-D-glucopyranoside against coxsackie virus B3.
    Zhu H; Zhang Y; Ye G; Li Z; Zhou P; Huang C
    Biol Pharm Bull; 2009 Jan; 32(1):68-73. PubMed ID: 19122283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
    Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
    Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3.
    Wang Y; Zhuan X; Peng Y; Li Q; Huang C; Huang H; Liang Z; Wang Q; Chang J
    Acta Virol; 2021; 65(1):58-67. PubMed ID: 33827222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
    Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a C-type CpG ODN on CVB3-infected mice].
    Yang L; Sun WQ; Wang L; Wang XL; Wan M; Yu YL; Wang LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):115-7. PubMed ID: 19174007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
    Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats.
    Zhang Y; Zhu H; Ye G; Huang C; Yang Y; Chen R; Yu Y; Cui X
    Life Sci; 2006 Mar; 78(17):1998-2005. PubMed ID: 16309710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
    Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
    Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of astragalus membranaceus on coxsackie B-3 virus RNA replication.
    Peng T; Yang Y; Riesemann H; Kandolf R
    Chin Med Sci J; 1995 Sep; 10(3):146-50. PubMed ID: 8580483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
    J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect and mechanism of Astragalus membranaceus on coxsackie B3 virus RNA in mice].
    Peng TQ; Yang YZ; Kandolf R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Nov; 14(11):664-6. PubMed ID: 7703635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
    Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
    J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Astragalus membranaceus on electrophysiological activities of acute experimental Coxsackie B3 viral myocarditis in mice].
    Rui T; Yang YZ; Zhou TS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 May; 14(5):292-4, 262. PubMed ID: 7950216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
    Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
    J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of aqueous extract from Spatholobus suberectus Dunn. against coxsackievirus B3 in mice.
    Pang J; Guo JP; Jin M; Chen ZQ; Wang XW; Li JW
    Chin J Integr Med; 2011 Oct; 17(10):764-9. PubMed ID: 21717161
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Fu Q; Gao L; Fu X; Meng Q; Lu Z
    J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.